GT Biopharma, Inc. (GTBP)
0.4291
-0.02
(-4.64%)
USD |
NASDAQ |
Feb 24, 13:47
GT Biopharma Research and Development Expense (Quarterly) : 0.634M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 4.216M |
| Lyell Immunopharma, Inc. | 25.61M |
| Geron Corp. | 21.07M |
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| Crinetics Pharmaceuticals, Inc. | 89.45M |